These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 35112308)

  • 1. Evaluation of stress myocardial blood flow patterns in patients with apical hypertrophic cardiomyopathy.
    Calabretta R; Kokomani A; Fumagalli C; Olivotto I; Camici PG; Hacker M; Sciagrà R
    J Nucl Cardiol; 2022 Aug; 29(4):1946-1951. PubMed ID: 35112308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of coronary microvascular dysfunction in symptomatic hypertrophic cardiomyopathy.
    Knaapen P; Germans T; Camici PG; Rimoldi OE; ten Cate FJ; ten Berg JM; Dijkmans PA; Boellaard R; van Dockum WG; Götte MJ; Twisk JW; van Rossum AC; Lammertsma AA; Visser FC
    Am J Physiol Heart Circ Physiol; 2008 Feb; 294(2):H986-93. PubMed ID: 18156203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of two software systems for quantification of myocardial blood flow in patients with hypertrophic cardiomyopathy.
    Yalcin H; Valenta I; Zhao M; Tahari A; Lu DY; Higuchi T; Yalcin F; Kucukler N; Soleimanifard Y; Zhou Y; Pomper MG; Abraham TP; Tsui B; Lodge MA; Schindler TH; Roselle Abraham M
    J Nucl Cardiol; 2019 Aug; 26(4):1243-1253. PubMed ID: 29359273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Diffuse Subendocardial Hypoperfusion on Left Ventricular Cavity Size by
    Yalçin H; Valenta I; Yalçin F; Corona-Villalobos C; Vasquez N; Ra J; Kucukler N; Tahari A; Pozios I; Zhou Y; Pomper M; Abraham TP; Schindler TH; Abraham MR
    Am J Cardiol; 2016 Dec; 118(12):1908-1915. PubMed ID: 27771003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apical variant hypertrophic cardiomyopathy "multimodality imaging evaluation".
    Huang G; Fadl SA; Sukhotski S; Matesan M
    Int J Cardiovasc Imaging; 2020 Mar; 36(3):553-561. PubMed ID: 31853820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of quantitative myocardial positron emission tomography for risk stratification in patients with hypertrophic cardiomyopathy: a 2016 reappraisal.
    Castagnoli H; Ferrantini C; Coppini R; Passeri A; Baldini K; Berti V; Cecchi F; Olivotto I; Sciagrà R
    Eur J Nucl Med Mol Imaging; 2016 Dec; 43(13):2413-2422. PubMed ID: 27527796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial blood flow and left ventricular functional reserve in hypertrophic cardiomyopathy: a
    Sciagrà R; Calabretta R; Cipollini F; Passeri A; Castello A; Cecchi F; Olivotto I; Pupi A
    Eur J Nucl Med Mol Imaging; 2017 May; 44(5):866-875. PubMed ID: 28050630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial contrast echocardiography assessment of perfusion abnormalities in hypertrophic cardiomyopathy.
    Roldan P; Ravi S; Hodovan J; Belcik JT; Heitner SB; Masri A; Lindner JR
    Cardiovasc Ultrasound; 2022 Sep; 20(1):23. PubMed ID: 36117179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of pixel-wise parametric mapping of myocardial blood flow with ¹³NH₃ PET in patients with hypertrophic cardiomyopathy.
    Sciagrà R; Passeri A; Cipollini F; Castagnoli H; Olivotto I; Burger C; Cecchi F; Pupi A
    Eur J Nucl Med Mol Imaging; 2015 Sep; 42(10):1581-8. PubMed ID: 26121929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stress Myocardial Blood Flow Heterogeneity Is a Positron Emission Tomography Biomarker of Ventricular Arrhythmias in Patients With Hypertrophic Cardiomyopathy.
    Lu DY; Yalçin H; Yalçin F; Zhao M; Sivalokanathan S; Valenta I; Tahari A; Pomper MG; Abraham TP; Schindler TH; Abraham MR
    Am J Cardiol; 2018 May; 121(9):1081-1089. PubMed ID: 29678336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidental spade-shaped FDG uptake in the left ventricular apex suggests apical hypertrophic cardiomyopathy.
    Katagiri M; Nakahara T; Murata M; Ogata Y; Matsusaka Y; Iwabuchi Y; Yamada Y; Fukuda K; Jinzaki M
    Ann Nucl Med; 2017 Jun; 31(5):399-406. PubMed ID: 28364376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced global myocardial perfusion reserve in DCM and HCM patients assessed by CMR-based velocity-encoded coronary sinus flow measurements and first-pass perfusion imaging.
    Bietenbeck M; Florian A; Shomanova Z; Meier C; Yilmaz A
    Clin Res Cardiol; 2018 Nov; 107(11):1062-1070. PubMed ID: 29774406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inline perfusion mapping provides insights into the disease mechanism in hypertrophic cardiomyopathy.
    Camaioni C; Knott KD; Augusto JB; Seraphim A; Rosmini S; Ricci F; Boubertakh R; Xue H; Hughes R; Captur G; Lopes LR; Brown LAE; Manisty C; Petersen SE; Plein S; Kellman P; Mohiddin SA; Moon JC
    Heart; 2020 Jun; 106(11):824-829. PubMed ID: 31822572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of intravascular and extravascular mechanisms of myocardial perfusion abnormalities in obstructive hypertrophic cardiomyopathy by myocardial contrast echocardiography.
    Soliman OI; Knaapen P; Geleijnse ML; Dijkmans PA; Anwar AM; Nemes A; Michels M; Vletter WB; Lammertsma AA; ten Cate FJ
    Heart; 2007 Oct; 93(10):1204-12. PubMed ID: 17488767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher incidence of vasodilator-induced left ventricular cavity dilation by PET when compared to treadmill exercise-ECHO in hypertrophic cardiomyopathy.
    Lu DY; Yalçin H; Sivalokanathan S; Greenland GV; Vasquez N; Yalçin F; Zhao M; Valenta I; Ganz P; Pampaloni MH; Zimmerman S; Schindler TH; Abraham TP; Abraham MR
    J Nucl Cardiol; 2020 Dec; 27(6):2031-2043. PubMed ID: 30456498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of alcohol septal ablation on coronary microvascular function and myocardial energetics in hypertrophic obstructive cardiomyopathy.
    Timmer SA; Knaapen P; Germans T; Dijkmans PA; Lubberink M; Ten Berg JM; Ten Cate FJ; Rüssel IK; Götte MJ; Lammertsma AA; van Rossum AC
    Am J Physiol Heart Circ Physiol; 2011 Jul; 301(1):H129-37. PubMed ID: 21490327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of PET-measured myocardial flow reserve with echocardiography-estimated pulmonary artery systolic pressure in patients with hypertrophic cardiomyopathy.
    Zhao M; Liu M; Leal JP; Tsui BMW; Wong DF; Pomper MG; Zhou Y
    PLoS One; 2019; 14(3):e0212573. PubMed ID: 30893304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of delayed enhancement by magnetic resonance to myocardial perfusion by positron emission tomography in hypertrophic cardiomyopathy.
    Bravo PE; Zimmerman SL; Luo HC; Pozios I; Rajaram M; Pinheiro A; Steenbergen C; Kamel IR; Wahl RL; Bluemke DA; Bengel FM; Abraham MR; Abraham TP
    Circ Cardiovasc Imaging; 2013 Mar; 6(2):210-7. PubMed ID: 23418294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positron-emission tomography myocardial blood flow quantification in hypertrophic cardiomyopathy.
    Sciagrà R
    Q J Nucl Med Mol Imaging; 2016 Dec; 60(4):354-61. PubMed ID: 27611709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial Perfusion Defects in Hypertrophic Cardiomyopathy Mutation Carriers.
    Hughes RK; Camaioni C; Augusto JB; Knott K; Quinn E; Captur G; Seraphim A; Joy G; Syrris P; Elliott PM; Mohiddin S; Kellman P; Xue H; Lopes LR; Moon JC
    J Am Heart Assoc; 2021 Aug; 10(15):e020227. PubMed ID: 34310159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.